Improving power in PSA response analyses of metastatic castration-resistant prostate cancer trials.
BMC Cancer
; 22(1): 111, 2022 Jan 26.
Article
in En
| MEDLINE
| ID: mdl-35081926
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Drug Monitoring
/
Prostatic Neoplasms, Castration-Resistant
Limits:
Humans
/
Male
Language:
En
Journal:
BMC Cancer
Journal subject:
NEOPLASIAS
Year:
2022
Document type:
Article
Affiliation country: